合成路线1
该中间体在本合成路线中的序号:
(VI) The condensation of piperidine-4-carboxylic acid (VI) with ethyl chloroformate (VII) by means of Na2CO3 in toluene/water gives 1-(ethoxycarbonyl)piperidine-4-carboxylic acid (VIII), which is treated with SOCl2 to yield the corresponding acyl chloride (IX). The Friedel-Crafts condensation of (IX) with refluxing 1,3-difluorobenzene (X) by means of AlCl3 gives 4-(2,4-difluorobenzoyl)piperidine-1-carboxylic acid ethyl ester (XI), which is treated with concentrated HCl at 100 C to yield 4-(2,4-difluorobenzoyl)piperidine (XII). The condensation of piperidine (XII) with the 2-chloroethyl intermediate (V) by means of KI and NaHCO3 in refluxing acetonitrile affords the adduct (XIII), which is treated with hydroxylamine hydrochloride and KOH in refluxing pyridine/ethanol to provide the corresponding oxime (XIV). Finally, this compound is cyclized by means of KOH in refluxing water or with NaH in refluxing THF to afford in both cases the target 1,2-benzisoxazole.
【1】
Dalmases Barjoan, P.; Bosch Rovira, A.; Marquillas Olondriz, F.; Caldero Ges, J.M. (Vita-Invest, SA); Process for the preparation of 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidino]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidine-4-one. ES 2050069 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(V) |
23044 |
3-(2-chloroethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
|
63234-80-0 |
C11H15ClN2O |
详情 | 详情
|
(VI) |
17402 |
4-nipecotic acid;piperidine-4-carboxylic acid;p-nipecotic acid; Isonipecotic acid; Hexahydroisonicotinic acid; 4-Piperidinecarboxylic acid |
498-94-2 |
C6H11NO2 |
详情 | 详情
|
(VII) |
11229 |
1-[(Chlorocarbonyl)oxy]ethane;ethyl carbonochloridate; Carbonchloridic acid ethyl ester;Ethyl chloroformate;Ethyl chlorocarbonate |
541-41-3 |
C3H5ClO2 |
详情 | 详情
|
(VIII) |
50868 |
1-(ethoxycarbonyl)-4-piperidinecarboxylic acid
|
|
C9H15NO4 |
详情 |
详情
|
(IX) |
50869 |
ethyl 4-(chlorocarbonyl)-1-piperidinecarboxylate
|
|
C9H14ClNO3 |
详情 |
详情
|
(X) |
13095 |
m-Difluorobenzene; 1,3-Difluorobenzene
|
372-18-9 |
C6H4F2 |
详情 | 详情
|
(XI) |
50870 |
ethyl 4-(2,4-difluorobenzoyl)-1-piperidinecarboxylate
|
|
C15H17F2NO3 |
详情 |
详情
|
(XII) |
23041 |
(2,4-difluorophenyl)(4-piperidinyl)methanone
|
|
C12H13F2NO |
详情 |
详情
|
(XIII) |
50871 |
3-[2-[4-(2,4-difluorobenzoyl)-1-piperidinyl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
|
|
C23H27F2N3O2 |
详情 |
详情
|
(XIV) |
50872 |
3-(2-[4-[(2,4-difluorophenyl)(hydroxyimino)methyl]-1-piperidinyl]ethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one
|
|
C23H28F2N4O2 |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(I) The reaction of piperidine-4-carboxylic acid (I) with formic acid and acetic anhydride gives 1-formylpiperidine-4-carboxylic acid (II), which is treated with SOCl2 and acetic anhydride to yield the corresponding acyl chloride (III). The Friedel-Crafts condensation of (III) with refluxing 1,3-difluorobenzene (IV) by means of AlCl3 affords 4-(2,4-difluorobenzoyl)-1-formylpiperidine (V), which is treated with hydroxylamine in refluxing ethanol to give the corresponding oxime (VI). The cyclization of (VI) by means of NaH in hot THF/DMF yields 6-fluoro-3-(1-formylpiperidin-4-yl)-1,2-benzisoxazole (VII), which is treated with HCl in refluxing ethanol to afford 6-fluoro-3-(4-piperidyl)-1,2-benzisoxazole (VIII). Finally, this compound is condensed with 4-(3-chloropropoxy)-3-methoxyacetophenone (IX) by means of K2CO3 in hot DMF.
The intermediate 4-(3-chloropropoxy)-3-methoxyacetophenone (IX) can be obtained by condensation of 4-hydroxy-3-methoxyacetophenone (IX) with 3-chcloropropyl bromide (X) by means of NaH or K2CO3 in DMF.
【1】
Corbett, R.; Bordeau, K.J.; Helsley, G.C.; Szewczak, M.R.; Wilmot, C.A.; Chiang, Y.; Hartman, H.B.; Conway, P.G.; Glamkowski, E.J.; Strupczewski, J.T.; 3-[[(Aryloxy)alkyl]piperidinyl]-1,2-benzisoxazoles as D2/5-HT2 antagonists with potential atypical antipsychotic activity: Antipsychotic profile of iloperidone (HP 873). J Med Chem 1995, 38, 7, 1119-31. |
【2】
Strupczewski, J.T.; Helsley, G.C.; Chiang, Y.; Bordeau, K.J. (Aventis Pharmaceuticals, Inc.); N-(Aryloxyalkyl)heteroarylpiperidines and-heteroarylpiperazines, a process for their preparation and their use as medicaments. EP 0402644; JP 1991063263 .
|
【3】
Strupczewski, J.T.; Helsley, G.C.; Chiang, Y.; Bordeau, K.J.; Glamkowski, E.J. (Aventis Pharmaceuticals, Inc.); Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics. EP 0542136; EP 0612318; EP 0730452; EP 0957102; EP 0959075; EP 0959076; EP 0963984; JP 1995501055; JP 1997511215; US 5364866; US 5776963; WO 9309102; WO 9511680 . |
【4】
Mucke, H.A.M.; Castaner, J.; Iloperidone. Drugs Fut 2000, 25, 1, 29.
|
【5】
Strupczewski, J.T.; Allen, R.C.; Gardner, B.A. (Aventis Pharmaceuticals, Inc.); 3-(4-Piperidyl)-1,2-benzisoxazoles. US 4355037 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17402 |
4-nipecotic acid;piperidine-4-carboxylic acid;p-nipecotic acid; Isonipecotic acid; Hexahydroisonicotinic acid; 4-Piperidinecarboxylic acid |
498-94-2 |
C6H11NO2 |
详情 | 详情
|
(II) |
32031 |
1-Formyl-4-piperidinecarboxylic acid
|
84163-42-8 |
C7H11NO3 |
详情 | 详情
|
(III) |
32032 |
1-formyl-4-piperidinecarbonyl chloride
|
|
C7H10ClNO2 |
详情 |
详情
|
(IV) |
13095 |
m-Difluorobenzene; 1,3-Difluorobenzene
|
372-18-9 |
C6H4F2 |
详情 | 详情
|
(V) |
32033 |
4-(2,4-difluorobenzoyl)-1-piperidinecarbaldehyde
|
|
C13H13F2NO2 |
详情 |
详情
|
(VI) |
32034 |
4-[(2,4-difluorophenyl)(hydroxyimino)methyl]-1-piperidinecarbaldehyde
|
|
C13H14F2N2O2 |
详情 |
详情
|
(VII) |
32035 |
4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinecarbaldehyde
|
|
C13H13FN2O2 |
详情 |
详情
|
(VIII) |
17910 |
6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazole
|
|
C12H13FN2O |
详情 |
详情
|
(IX) |
22605 |
4-(3-Chloropropoxy)-3-Methoxyacetophenone;3-(4-Acetyl-2-methoxyphenoxy)propyl chloride;1-(4-(3-chloropropoxy)-3-methoxyphenyl)ethanone;1-[4-(3-chloropropoxy)-3-methoxyphenyl]-1-ethanone |
58113-30-7 |
C12H15ClO3 |
详情 | 详情
|
(X) |
22604 |
1-(4-hydroxy-3-methoxyphenyl)-1-ethanone;Acetovanillone;4’-hydroxy-3’-methoxyacetophenone;1-(4-hydroxy-3-methoxyphenyl)ethanone |
498-02-2 |
C9H10O3 |
详情 | 详情
|
(XI) |
10358 |
1-Bromo-3-chloropropane
|
109-70-6 |
C3H6BrCl |
详情 | 详情
|
合成路线3
该中间体在本合成路线中的序号:
(X) 2) Racemic MDL-100907 (VII) can also be obtained by reaction of piperidine-4-carboxylic acid (X) with di-tert-butyl dicarbonate (XI) by means of NaOH in tert-butanol/ water, giving piperidine-1,4-dicarboxylic acid 1-mono-tert-butyl ester (XII), which is treated with N,O-dimethylhydroxylamine (XIII) and carbonyldiimidazole (CDI) in dichloromethane to afford the methoxy(methyl)amide (XIV). The condensation of (XIV) with veratrole (VI) by means of BuLi in THF gives 4-(2,3-dimethoxybenzoyl)-piperidine-1-carboxylic acid tert-butyl ester (XV), which is decarboxylated by means of trifluoroacetic acid, yielding ketone (XVI). The condensation of (XVI) with 2-(4-fluorophenyl)ethyl bromide (II) by means of K2CO3 in DMF affords 1-(2,3-dimethoxyphenyl)-1-[1-[2-(4-fluorophenyl)-ethyl]piperidin-4-yl]methanone (XVII). Finally, this compound is reduced with NaBH4 in methanol
【1】
Castaner, J.; Sorbera, L.A.; Silvestre, J.S.; MDL-100907. Drugs Fut 1998, 23, 9, 955.
|
【2】
Carr, A.A.; Kane, J.M.; Hay, D.A. (Merrell Pharmaceuticals, Inc.); (+)-*-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol. EP 0531410; JP 1993507482; US 5134149; WO 9118602 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(II) |
17394 |
1-(2-bromoethyl)-4-fluorobenzene
|
|
C8H8BrF |
详情 |
详情
|
(VI) |
17398 |
2-methoxyphenyl methyl ether; Veratrole; 1,2-dimethoxybenzene
|
91-16-7 |
C8H10O2 |
详情 | 详情
|
(VII) |
17399 |
(2,3-dimethoxyphenyl)[1-(4-fluorophenethyl)-4-piperidinyl]methanol
|
|
C22H28FNO3 |
详情 |
详情
|
(X) |
17402 |
4-nipecotic acid;piperidine-4-carboxylic acid;p-nipecotic acid; Isonipecotic acid; Hexahydroisonicotinic acid; 4-Piperidinecarboxylic acid |
498-94-2 |
C6H11NO2 |
详情 | 详情
|
(XI) |
13214 |
Di-tert-butyldicarbonate; Dicarbonic acid bis(1,1-dimethylethyl) ester; dicarbonic acid di-tert-butyl ester
pyrocarbonic acid di-tert-butyl ester; bis(1,1-dimethylethyl) dicarbonate
di-tert-butyl pyrocarbonate
|
24424-99-5 |
C10H18O5 |
详情 | 详情
|
(XII) |
17404 |
1-(tert-butoxycarbonyl)-4-piperidinecarboxylic acid; 1-BOC-piperidine-4-carboxylic acid; N-Boc-isonipecotic acid
|
84358-13-4 |
C11H19NO4 |
详情 | 详情
|
(XIII) |
13361 |
(Methoxyamino)methane; N,O-Dimethylhydroxylamine
|
1117-97-1 |
C2H7NO |
详情 | 详情
|
(XIV) |
17406 |
tert-butyl 4-[[methoxy(methyl)amino]carbonyl]tetrahydro-1(2H)-pyridinecarboxylate
|
|
C13H24N2O4 |
详情 |
详情
|
(XV) |
17407 |
tert-butyl 4-(2,3-dimethoxybenzoyl)tetrahydro-1(2H)-pyridinecarboxylate
|
|
C19H27NO5 |
详情 |
详情
|
(XVI) |
17408 |
(2,3-dimethoxyphenyl)(4-piperidinyl)methanone
|
|
C14H19NO3 |
详情 |
详情
|
(XVII) |
17409 |
(2,3-dimethoxyphenyl)[1-(4-fluorophenethyl)-4-piperidinyl]methanone
|
|
C22H26FNO3 |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(VIII) The monosulfonation of orcinol (I) with 2-chlorobenzenesulfonyl chloride (II) in ethyl ether/aqueous NaHCO3 gives the monosulfonate (III), which is condensed with 4-(methanesulfonyloxymethyl)piperidine-1-carboxylic acid tert-butyl ester (IV) by means of NaH in DMF to yield the aryl ether (V). The deprotection of (V) with 4N HCl in dioxane affords the piperidine (VI), which is finally treated with amidinosulfonic acid (VII) and TEA in DMF.
The 4-(methanesulfonyloxymethyl)piperidine-1-carboxylic acid tert-butyl ester (IV) has been obtained as follows: The reaction of piperidine-4-carboxylic acid (VIII) with Boc2O and NaHCO3 in dioxane/water gives the protected piperidine (IX), which is reduced at the carboxyl group by means of BH3/THF yielding the carbinol (X). Finally, this compound is mesylated with MsCl and TEA in dichloromethane to afford the target intermediate.
【1】
Soll, R.M.; Spurlino, J.; Murphy, L.; Lu, T.; Salemme, F.R.; Bone, R.; Illig, C.R.; Tomczuk, B.E.; Structure-activity and crystallographic analysis of a new class of non-amide-based thrombin inhibitor. Bioorg Med Chem Lett 2000, 10, 1, 79.
|
【2】
Zetter, B.R.; Smith, R. (Children's Medical Center Corp.); Treatment of human prostate cancer with spermine. WO 9711691 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
27257 |
5-Methyl-1,3-benzenediol; Orcinol
|
505-15-4 |
C7H8O2 |
详情 | 详情
|
(II) |
30817 |
2-chlorobenzenesulfonyl chloride
|
2905-23-9 |
C6H4Cl2O2S |
详情 | 详情
|
(III) |
30818 |
3-hydroxy-5-methylphenyl 2-chlorobenzenesulfonate
|
|
C13H11ClO4S |
详情 |
详情
|
(IV) |
40396 |
tert-butyl 4-([[methyl(dimethylene)-lambda(6)-sulfanyl]oxy]methyl)-1-piperidinecarboxylate
|
|
C14H27NO3S |
详情 |
详情
|
(V) |
40397 |
tert-butyl 4-[(3-[[(2-chlorophenyl)sulfonyl]oxy]-5-methylphenoxy)methyl]-1-piperidinecarboxylate
|
|
C24H30ClNO6S |
详情 |
详情
|
(VI) |
40398 |
3-methyl-5-(4-piperidinylmethoxy)phenyl 2-chlorobenzenesulfonate
|
|
C19H22ClNO4S |
详情 |
详情
|
(VII) |
15984 |
amino(imino)methanesulfonic acid
|
|
CH4N2O3S |
详情 |
详情
|
(VIII) |
17402 |
4-nipecotic acid;piperidine-4-carboxylic acid;p-nipecotic acid; Isonipecotic acid; Hexahydroisonicotinic acid; 4-Piperidinecarboxylic acid |
498-94-2 |
C6H11NO2 |
详情 | 详情
|
(IX) |
17404 |
1-(tert-butoxycarbonyl)-4-piperidinecarboxylic acid; 1-BOC-piperidine-4-carboxylic acid; N-Boc-isonipecotic acid
|
84358-13-4 |
C11H19NO4 |
详情 | 详情
|
(X) |
40399 |
tert-butyl 4-(hydroxymethyl)-1-piperidinecarboxylate
|
|
C11H21NO3 |
详情 |
详情
|
合成路线5
该中间体在本合成路线中的序号:
(I) The reaction of piperidine-4-carboxylic acid (I) with SOCl2 gives the acyl chloride (II), which is treated with methanol to yield the methyl ester (III). Finally, this compound is condensed with 4-chloro-1-(4-fluorophenyl)-1-butanone (IV) by means of K2CO3 in refluxing acetone.
【1】
Kar, K.; Pandey, S.K.; Tripathi, R.C.; Saxena, A.K.; Synthesis and SAR studies of 1-substituted-n-(4-alkoxycarbonylpiperidin-1-yl)alkanes as potent antiarrhythmic agents. Bioorg Med Chem Lett 1999, 9, 18, 2693.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17402 |
4-nipecotic acid;piperidine-4-carboxylic acid;p-nipecotic acid; Isonipecotic acid; Hexahydroisonicotinic acid; 4-Piperidinecarboxylic acid |
498-94-2 |
C6H11NO2 |
详情 | 详情
|
(II) |
38417 |
4-piperidinecarbonyl chloride
|
|
C6H10ClNO |
详情 |
详情
|
(III) |
38418 |
methyl 4-piperidinecarboxylate; Isonipecotic acid methyl ester; 4-piperidinecarboxylic acid methyl ester
|
2971-79-1 |
C7H13NO2 |
详情 | 详情
|
(IV) |
35864 |
4-chloro-1-(4-fluorophenyl)-1-butanone
|
3874-54-2 |
C10H10ClFO |
详情 | 详情
|
合成路线6
该中间体在本合成路线中的序号:
(I) Protection of isonipecotic acid (I) as the trifluoroacetamide (II), followed by treatment with thionyl chloride, afforded acid chloride (III). Friedel-Crafts reaction of acid chloride (III) with bromobenzene (IV) gave ketone (V), which was further protected as the ethylene ketal (VI). The trifluoroacetamide group of (VI) was then hydrolyzed to amine (VII) using K2CO3 in MeOH. Condensation of amine (VII) with N-Boc-4-piperidone (VIII) in the presence of titanium isopropoxide, and subsequent addition of diethylaluminum cyanide to the intermediate iminium salt, provided amino nitrile (IX). Treatment of (IX) with methylmagnesium bromide afforded the methyl derivative (X). Acid hydrolysis of the ketal and Boc groups of (X), followed by reprotection with Boc2O, furnished ketone (XI). Oxime formation in (XI) with O-ethyl hydroxylamine produced a 1.5:1 mixture of (E)- and (Z)-isomers, which were separated by silica gel chromatography. Previous equilibration of the mixture under acidic conditions favored the desired (Z)-isomer (XII). The Boc protecting group of (XII) was then removed by treatment with trifluoroacetic acid. The resultant piperidine (XIII) was finally coupled with 2,4-dimethylnicotinic acid N-oxide (XIV) using EDC and HOBt to furnish the title compound.
【1】
Palani, A.; et al.; Discovery of 4-[(Z)-(4-bromophenyl)-(ethoxyimino)methyl]-1'-[(2,4-dimethyl-3-pyridinyl)carbonyl]-4'-methyl-1,4'-bipiperidine N-oxide (SCH 351125). An orally bioavailable human CCR5 antagonist for the treatment of HIV infection. J Med Chem 2001, 44, 21, 3339. |
【2】
Palani, A.; et al.; Synthesis, SAR, and biological evaluation of oximino-piperidino-pieperidine amides. 1. Orally bioavailable CCR5 receptor antagonists with potent anti-HIV activity. J Med Chem 2002, 45, 14, 3143.
|
【3】
McCombie, S.W.; Clader, J.W.; Baroudy, B.M.; McKittrick, B.A.; Josien, H.B.; Tagat, J.R.; Vice, S.F.; Steensma, R.; Laughlin, M.A.; Miller, M.W.; Neustadt, B.R.; Palani, A. (Schering Corp.); Piperidine derivs. useful as CCR5 antagonists. EP 1175402; WO 0066559 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
17402 |
4-nipecotic acid;piperidine-4-carboxylic acid;p-nipecotic acid; Isonipecotic acid; Hexahydroisonicotinic acid; 4-Piperidinecarboxylic acid |
498-94-2 |
C6H11NO2 |
详情 | 详情
|
(II) |
51847 |
1-(2,2,2-trifluoroacetyl)-4-piperidinecarboxylic acid
|
|
C8H10F3NO3 |
详情 |
详情
|
(III) |
51848 |
1-(2,2,2-trifluoroacetyl)-4-piperidinecarbonyl chloride
|
|
C8H9ClF3NO2 |
详情 |
详情
|
(IV) |
13365 |
Monobromobenzene; 1-Bromobenzene;Phenylbromide;bromobenzene |
108-86-1 |
C6H5Br |
详情 | 详情
|
(V) |
51849 |
1-[4-(4-bromobenzoyl)-1-piperidinyl]-2,2,2-trifluoro-1-ethanone
|
|
C14H13BrF3NO2 |
详情 |
详情
|
(VI) |
51850 |
1-[4-[2-(4-bromophenyl)-1,3-dioxolan-2-yl]-1-piperidinyl]-2,2,2-trifluoro-1-ethanone
|
|
C16H17BrF3NO3 |
详情 |
详情
|
(VII) |
51851 |
4-[2-(4-bromophenyl)-1,3-dioxolan-2-yl]piperidine
|
|
C14H18BrNO2 |
详情 |
详情
|
(VIII) |
18620 |
tert-butyl 4-oxo-1-piperidinecarboxylate;BOC-Piperidone;N-(tert-Butoxycarbonyl)-4-piperidone; N-Boc-4-piperidone |
79099-07-3 |
C10H17NO3 |
详情 | 详情
|
(IX) |
51852 |
|
|
C25H34BrN3O4 |
详情 |
详情
|
(X) |
51853 |
|
|
C25H37BrN2O4 |
详情 |
详情
|
(XI) |
51854 |
|
|
C23H33BrN2O3 |
详情 |
详情
|
(XII) |
51855 |
|
|
C25H38BrN3O3 |
详情 |
详情
|
(XIII) |
51856 |
|
|
C20H30BrN3O |
详情 |
详情
|
(XIV) |
51857 |
3-carboxy-2,4-dimethyl-1-pyridiniumolate
|
|
C8H9NO3 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(XI) Treatment of 1-bromo-3,3-dimethyl-2-butanone (I) with hexamethylenetetraamine affords the quaternary salt (II), which is then hydrolyzed to amino ketone (III) under acidic conditions (1-3). Alternatively, reaction of butanone (I) with sodium azide in acetone gives the azido derivative (IV), which is reduced with H2 over Pd/C in methanol to yield 1-amino-3,3-dimethyl-2-butanone (III). Acylation of amine (III) with 2-chloroacetyl chloride by means of triethylamine in dichloromethane yields the chloroacetamide (V), which is cyclized in POCl3 at 105 ºC to provide 5-tert-butyl-2-(chloromethyl)oxazole (VI) (1-4). Condensation of chloride (VI) with thiourea gives the S-alkylated thiouronium salt (VII), which is then submitted to alkaline hydrolysis followed by condensation with 2-amino-5-bromothiazole (VIII) under phase-transfer conditions in the presence of tetrabutylammonium sulfate, leading to thioether (IX) (1-3). Acylation of aminothiazole (IX) with 1-Boc-piperidine-4-carboxylic acid (X) —obtained by reaction of piperidine-4-carboxylic acid (XI) with Boc2O and NaOH in dioxane/acetonitrile— by means of EDAC and DMAP in DMF/dichloromethane yields the carboxamide (XII), which is finally deprotected upon treatment with trifluoroacetic acid (1-3) or by means of HCl in hot dioxane/CHCl (4). Scheme 1.
【1】
Xiao, H.-Y., Misra, R.N. (Bristol-Myers Squibb Co.). N-[5-[[[5-Alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases. CA 2394552, EP1240166, JP 2003516987, WO 2001044242. |
【2】
Xiao, H.-Y., Misra, R.N. (Bristol-Myers Squibb Co.). N-[5-[[[5-Alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases. CA 2417254, EP 1303513, JP 2004509857, WO 2002010162. |
【3】
Kim, K.S., Kimball, D., Cai, Z.-W. et al. (Bristol-Myers Squibb Co.). Aminothiazole inhibitors of cyclin dependent kinases. US 6262096. |
【4】
Misra, N.R., Xiao, H., Kim, K.S. et al. N-(Cycloalkylamino)acyl-2-aminothiazole inhibitors of cyclin-dependent kinase 2. N-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide (BMS-387032), a highly efficacious and selective antitumor agent. J Med Chem 2004, 47(7): 1719-28. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
30809 |
1-bromo-3,3-dimethyl-2-butanone
|
5469-26-1 |
C6H11BrO |
详情 | 详情
|
(II) |
65780 |
|
|
C12H23BrN4O |
详情 | 详情
|
(III) |
58415 |
1-amino-3,3-dimethyl-2-butanone
|
82962-91-2 |
C6H13NO |
详情 | 详情
|
(IV) |
58414 |
1-azido-3,3-dimethyl-2-butanone
|
76779-98-1 |
C6H11N3O |
详情 | 详情
|
(V) |
58416 |
2-chloro-N-(3,3-dimethyl-2-oxobutyl)acetamide
|
|
C8H14ClNO2 |
详情 |
详情
|
(VI) |
58417 |
5-(tert-butyl)-2-(chloromethyl)-1,3-oxazole
|
224441-73-0 |
C8H12ClNO |
详情 | 详情
|
(VII) |
58418 |
2-({[amino(imino)methyl]sulfanyl}methyl)-5-(tert-butyl)-1,3-oxazole
|
345629-22-3 |
C9H15N3OS |
详情 | 详情
|
(VIII) |
65781 |
2-Amino-5-bromothiazole monohydrobromide; 5-Bromothiazol-2-amine monohydrobromide |
61296-22-8 |
C3H3BrN2S.HBr |
详情 | 详情
|
(IX) |
58420 |
5-({[5-(tert-butyl)-1,3-oxazol-2-yl]methyl}sulfanyl)-1,3-thiazol-2-amine; 5-({[5-(tert-butyl)-1,3-oxazol-2-yl]methyl}sulfanyl)-1,3-thiazol-2-ylamine
|
224436-97-9 |
C11H15N3OS2 |
详情 | 详情
|
(X) |
17404 |
1-(tert-butoxycarbonyl)-4-piperidinecarboxylic acid; 1-BOC-piperidine-4-carboxylic acid; N-Boc-isonipecotic acid
|
84358-13-4 |
C11H19NO4 |
详情 | 详情
|
(XI) |
17402 |
4-nipecotic acid;piperidine-4-carboxylic acid;p-nipecotic acid; Isonipecotic acid; Hexahydroisonicotinic acid; 4-Piperidinecarboxylic acid |
498-94-2 |
C6H11NO2 |
详情 | 详情
|
(XII) |
65782 |
tert-Butyl 4-[[5-[[(5-tert-butyloxazol-2-yl)methyl]thio]thiazol-2-yl]carbamoyl]piperidine-1-carboxylate |
345629-23-4 |
C22H32N4O4S2 |
详情 | 详情
|
合成路线8
该中间体在本合成路线中的序号:
(III)
【1】
Strupczewski JT, Allen RC, Gardner BA, et al. 1985. Synthesis and neuroleptic activity of 3-(1-substituted-4-piperidinyl)-1,2-benzisoxazoles. J Med Chem, 28(6) : 761~769. |
【2】
Strupczewski JT, Bordeau KJ, Chiang YL, et al. 1995. 3-[[(aryloxy) alkyl] piperidinyl]-1,2-benzisoxazoles as D2/5-HT2 antagonists with potential atypical antipsychotic activity: antipsychotic profile of iloperidone. J Med Chem, 38(7): 1119~1131. |
【3】
Walsh DA, Franzyshen SK, Yanni JM. 1989. Synthesis and antiallergy activity of 4-(diarylhydroxymethyl)-1-[3-(aryloxy) propyl] piperidines and structurally related compounds. J Med Chem, 32(1): 105~118. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(II) |
22605 |
4-(3-Chloropropoxy)-3-Methoxyacetophenone;3-(4-Acetyl-2-methoxyphenoxy)propyl chloride;1-(4-(3-chloropropoxy)-3-methoxyphenyl)ethanone;1-[4-(3-chloropropoxy)-3-methoxyphenyl]-1-ethanone |
58113-30-7 |
C12H15ClO3 |
详情 | 详情
|
(X) |
32035 |
4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinecarbaldehyde
|
|
C13H13FN2O2 |
详情 |
详情
|
(I) |
22604 |
1-(4-hydroxy-3-methoxyphenyl)-1-ethanone;Acetovanillone;4’-hydroxy-3’-methoxyacetophenone;1-(4-hydroxy-3-methoxyphenyl)ethanone |
498-02-2 |
C9H10O3 |
详情 | 详情
|
(III) |
17402 |
4-nipecotic acid;piperidine-4-carboxylic acid;p-nipecotic acid; Isonipecotic acid; Hexahydroisonicotinic acid; 4-Piperidinecarboxylic acid |
498-94-2 |
C6H11NO2 |
详情 | 详情
|
(IV) |
32031 |
1-Formyl-4-piperidinecarboxylic acid
|
84163-42-8 |
C7H11NO3 |
详情 | 详情
|
(V) |
32032 |
1-formyl-4-piperidinecarbonyl chloride
|
|
C7H10ClNO2 |
详情 |
详情
|
(VI) |
13095 |
m-Difluorobenzene; 1,3-Difluorobenzene
|
372-18-9 |
C6H4F2 |
详情 | 详情
|
(VII) |
32033 |
4-(2,4-difluorobenzoyl)-1-piperidinecarbaldehyde
|
|
C13H13F2NO2 |
详情 |
详情
|
(VIII) |
32034 |
4-[(2,4-difluorophenyl)(hydroxyimino)methyl]-1-piperidinecarbaldehyde
|
|
C13H14F2N2O2 |
详情 |
详情
|
(IX) |
67149 |
(E)-4-[(2,4-difluorophenyl)(hydroxyimino)methyl]-1-piperidinecarbaldehyde |
|
C13H14F2N2O2 |
详情 | 详情
|
(XI) |
17910 |
6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazole
|
|
C12H13FN2O |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(VIII) N-Methylation of piperidine-4-carboxylic acid (VIII) by means of HCHO in the presence of H2 over Pd/C in H2O gives 1-methylpiperidine-4-carboxylic acid (IX), which by chlorination with (COCl)2 in the presence of DMF in refluxing CH2Cl2 furnishes 1-methylpiperidine-4-carbonyl chloride hydrochloride (X). Condensation of acid chloride (X) with Me2NH in the presence of Et3N in THF yields N,N,1-trimethylpiperidine-4-carboxamide (XI), which then condenses with 2,6-dibromopyridine (XII) in the presence of BuLi in methyl t-butyl ether (MTBE), affording (6-bromopyridin-2-yl)(1-methylpiperidin-4-yl)methanone (XIII). Amination of bromo derivative (XIII) with NH3 in the presence of Cu2O in ethylene glycol at 85 °C produces the desired intermediate (V) .
【1】
Kohlman, D.T., Mancuso, V., Cohen, M.P. et al. (Eli Lilly and Company). Pyridinoylpiperidines as 5-HT1F agonists. EP 1492786, JP 2005530722, JP 2010159272, US 2005222206, US 7423050, US 8044207, WO 2003084949. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(V) |
68622 |
(6-aminopyridin-2-yl)(1-methylpiperidin-4-yl)methanone |
|
C12H17N3O |
详情 | 详情
|
(VIII) |
17402 |
4-nipecotic acid;piperidine-4-carboxylic acid;p-nipecotic acid; Isonipecotic acid; Hexahydroisonicotinic acid; 4-Piperidinecarboxylic acid |
498-94-2 |
C6H11NO2 |
详情 | 详情
|
(IX) |
68625 |
1-methyl-4-Piperidinecarboxylicacid;1-methylpiperidine-4-carboxylic acid;1-methyl-Isonipecoticacid;4-Carboxy-N-methylpiperidine;N-Methylpiperidine-4-carboxylic acid |
68947-43-3 |
C7H13NO2 |
详情 | 详情
|
(X) |
68626 |
1-methylpiperidine-4-carbonyl chloride hydrochloride |
|
C7H12ClNO.HCl |
详情 | 详情
|
(XI) |
68627 |
N,N,1-trimethylpiperidine-4-carboxamide |
|
C9H18N2O |
详情 | 详情
|
(XII) |
10159 |
2,6-Dibromopyridine
|
626-05-1 |
C5H3Br2N |
详情 | 详情
|
(XIII) |
68628 |
(6-bromopyridin-2-yl)(1-methylpiperidin-4-yl)methanone |
|
C12H15BrN2O |
详情 | 详情
|